Hamed Karami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hamed Karami has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Smirnova
Georgia State University
2 shared publications - Gerardo Chowell
School of Public Health, Georgia State University, Atlanta, USA
2 shared publications - Svenn-Erik Mamelund
Centre for Research On Pandemics & Society (PANSOC), Oslo Metropolitan University, Oslo, Norway
2 shared publications Alexandra Smirnova
Department of Mathematics & Statistics, Georgia State University, Atlanta, USA
1 shared publication- Douglas J. LaFountain
Western Illinois Univ, 1 Univ Cir, Macomb, IL 61455 USA
1 shared publication - Mokhtar Aouina1 shared publication
Latest Publications
- Open Access
- 1 December 2026
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 11 (4) , 1624-1644
Modeling and control of highly pathogenic avian influenza in poultry using network disease dynamics
In light of the ongoing 2022-2025 HPAI outbreak in the U.S., which affects millions of commercial and backyard flocks, disrupts egg and meat production, and causes significant economic losses, it is important to develop biological models and optimization algorithms that conform to the U.S.-specific patterns of HPAI transmission and reflect control and prevention measures adopted in the USA. In this study, we introduce a partially stochastic network compartmental model to ascertain the progression and potential containment of HPAI virus in commercial flocks and wildlife. Parameters of the model get estimated using available data on wild bird migration, HPAI poultry outbreaks, and poultry farm inventory in different states of the U.S. The new model simulates HPAI virus transmission driven by wildlife dynamic, seasonality, and farm-to-farm relations. Unlike many prior global models, this framework is closely tailored to the U.S. HPAI statistics, farm structure, and current mitigation practices. The proposed network model, along with HPAI surveillance data, are used to analyze optimal control strategies aimed at lowering HPAI spread from wild birds to poultry. Our numerical experiments illustrate that the above control strategy is very powerful. In the absence of prevalent vaccination, these relatively inexpensive separation measures, such as covered runs and secure housing, help to prevent environmental contamination and the risk of HPAI transmission to domestic birds, thus protecting the flock and reducing depopulation.
- 1 December 2026
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 11 (4) , 1624-1644
Open AccessModeling and control of highly pathogenic avian influenza in poultry using network disease dynamics
In light of the ongoing 2022-2025 HPAI outbreak in the U.S., which affects millions of commercial and backyard flocks, disrupts egg and meat production, and causes significant economic losses, it is important to develop biological models and optimization algorithms that conform to the U.S.-specific patterns of HPAI transmission and reflect control and prevention measures adopted in the USA. In this study, we introduce a partially stochastic network compartmental model to ascertain the progression and potential containment of HPAI virus in commercial flocks and wildlife. Parameters of the model get estimated using available data on wild bird migration, HPAI poultry outbreaks, and poultry farm inventory in different states of the U.S. The new model simulates HPAI virus transmission driven by wildlife dynamic, seasonality, and farm-to-farm relations. Unlike many prior global models, this framework is closely tailored to the U.S. HPAI statistics, farm structure, and current mitigation practices. The proposed network model, along with HPAI surveillance data, are used to analyze optimal control strategies aimed at lowering HPAI spread from wild birds to poultry. Our numerical experiments illustrate that the above control strategy is very powerful. In the absence of prevalent vaccination, these relatively inexpensive separation measures, such as covered runs and secure housing, help to prevent environmental contamination and the risk of HPAI transmission to domestic birds, thus protecting the flock and reducing depopulation.
- Open Access
- 31 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-18
Global excess tuberculosis mortality during COVID-19: a country-level modeling study of policy and development correlates
Background: The COVID-19 pandemic disrupted global tuberculosis (TB) control efforts, leading to a surge in TB-related excess mortality, particularly in low- and middle-income countries. Pandemic mitigation measures, such as lockdowns, reallocation of healthcare resources, and reduced access to diagnosis and treatment, contributed to delayed TB care and disease progression. Quantifying this collateral damage is crucial to bolstering health system resilience. Methods: We estimated country-level excess TB mortality between 2020 and 2023 using annual TB mortality data reported by the World Health Organization (WHO). Our approach leverages the SubEpiPredict toolbox of the ensemble n-sub-epidemic modeling framework, calibrated to pre-pandemic trends (2010–2019) to forecast expected TB deaths in the absence of COVID-19 disruptions. We selected the best-fitting model based on AICc and compared projected and reported deaths to quantify excess mortality, incorporating both normal and Poisson error structures. We further examined associations between excess TB mortality and country-level indicators, including the COVID-19 Stringency Index, Global Health Security (GHS) Index, and Socio-demographic Index (SDI). It is also noteworthy that for each estimate of excess TB deaths, we provide an associated uncertainty. Results: Our global estimate of 755,876 excess TB deaths (95%CI: 591,099 to 965,015) aligns closely with the WHO estimate of approximately 700,000 excess deaths. Therefore, it can be estimated a global relative excess mortality of 12.8% (95%CI: 11.6% to 14.2%), compared to the WHO estimate of 14.6% (95% CI: 5.9% to 26.7%). We found substantial geographic heterogeneity, with the highest TB excess mortality rates observed in southern Africa, South Asia, and parts of South America. Countries with high GHS or SDI scores did not necessarily exhibit lower excess TB mortality, suggesting that pandemic-specific disruptions and competing priorities may have overridden structural advantages. Weak-to-moderate correlations were observed between excess mortality and pandemic stringency, peaking in 2021 and waning by 2022, possibly reflecting health system adaptation. Conclusion: This study presents a systematic, model-based analysis of global excess TB mortality during the COVID-19 pandemic, emphasizing disparities in pandemic response impacts across countries. The findings highlight the need for integrated and resilient public health systems capable of maintaining essential services amid global crises. Our methodology can support real-time monitoring of collateral effects of pandemics on endemic diseases and guide strategic investments in TB surveillance and care continuity.
- 31 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-18
Open AccessGlobal excess tuberculosis mortality during COVID-19: a country-level modeling study of policy and development correlates
Background: The COVID-19 pandemic disrupted global tuberculosis (TB) control efforts, leading to a surge in TB-related excess mortality, particularly in low- and middle-income countries. Pandemic mitigation measures, such as lockdowns, reallocation of healthcare resources, and reduced access to diagnosis and treatment, contributed to delayed TB care and disease progression. Quantifying this collateral damage is crucial to bolstering health system resilience. Methods: We estimated country-level excess TB mortality between 2020 and 2023 using annual TB mortality data reported by the World Health Organization (WHO). Our approach leverages the SubEpiPredict toolbox of the ensemble n-sub-epidemic modeling framework, calibrated to pre-pandemic trends (2010–2019) to forecast expected TB deaths in the absence of COVID-19 disruptions. We selected the best-fitting model based on AICc and compared projected and reported deaths to quantify excess mortality, incorporating both normal and Poisson error structures. We further examined associations between excess TB mortality and country-level indicators, including the COVID-19 Stringency Index, Global Health Security (GHS) Index, and Socio-demographic Index (SDI). It is also noteworthy that for each estimate of excess TB deaths, we provide an associated uncertainty. Results: Our global estimate of 755,876 excess TB deaths (95%CI: 591,099 to 965,015) aligns closely with the WHO estimate of approximately 700,000 excess deaths. Therefore, it can be estimated a global relative excess mortality of 12.8% (95%CI: 11.6% to 14.2%), compared to the WHO estimate of 14.6% (95% CI: 5.9% to 26.7%). We found substantial geographic heterogeneity, with the highest TB excess mortality rates observed in southern Africa, South Asia, and parts of South America. Countries with high GHS or SDI scores did not necessarily exhibit lower excess TB mortality, suggesting that pandemic-specific disruptions and competing priorities may have overridden structural advantages. Weak-to-moderate correlations were observed between excess mortality and pandemic stringency, peaking in 2021 and waning by 2022, possibly reflecting health system adaptation. Conclusion: This study presents a systematic, model-based analysis of global excess TB mortality during the COVID-19 pandemic, emphasizing disparities in pandemic response impacts across countries. The findings highlight the need for integrated and resilient public health systems capable of maintaining essential services amid global crises. Our methodology can support real-time monitoring of collateral effects of pandemics on endemic diseases and guide strategic investments in TB surveillance and care continuity.
- Open Access
- 12 June 2025
- Published by Springer Nature in Research Square
Global Excess Tuberculosis Mortality DuringCOVID-19: A Country-Level Modeling Study of Policy and Development Correlates
Background: The COVID-19 pandemic disrupted global tuberculosis (TB) con-trol efforts, leading to a surge in TB-related excess mortality, particularly inlow- and middle-income countries. Pandemic mitigation measures—such as lock-downs, reallocation of healthcare resources, and reduced access to diagnosis andtreatment—contributed to delayed TB care and disease progression. Quantifyingthis collateral damage is crucial to bolstering health system resilience. Methods: We estimated country-level excess TB mortality between 2020 and2023 using annual TB mortality data reported by the World Health Organization(WHO). Our approach leverages the SubEpiPredict toolbox of the ensemble sub-epidemic modeling framework, calibrated to pre-pandemic trends (2010–2019) toforecast expected TB deaths in the absence of COVID-19 disruptions. We selectedthe best-fitting model based on AICc and compared projected and reporteddeaths to quantify excess mortality, incorporating both normal and Poissonerror structures. We further examined associations between excess TB mortalityand country-level indicators, including the COVID-19 Stringency Index, GlobalHealth Security (GHS) Index, and Socio-demographic Index (SDI). Results: Our global estimate of 750,000 excess TB deaths aligns closely withWHO’s estimate of 700,000, while offering granular country-level insights withuncertainty bounds. We found substantial geographic heterogeneity, with thehighest TB excess mortality rates observed in southern Africa, South Asia, andparts of South America. Countries with high GHS or SDI scores did not nec-essarily exhibit lower excess TB mortality, suggesting that pandemic-specificdisruptions and competing priorities may have overridden structural advantages.Weak-to-moderate correlations were observed between excess mortality and pan-demic stringency, peaking in 2021 and waning by 2022, possibly reflecting healthsystem adaptation. Conclusion: This study presents a systematic, model-based analysis of globalexcess TB mortality during the COVID-19 pandemic, emphasizing disparities inpandemic response impacts across countries. The findings highlight the need forintegrated and resilient public health systems capable of maintaining essentialservices amid global crises. Our methodology can support real-time monitor-ing of collateral effects of pandemics on endemic diseases and guide strategicinvestments in TB surveillance and care continuity.
- 12 June 2025
- Published by Springer Nature in Research Square
Open AccessGlobal Excess Tuberculosis Mortality DuringCOVID-19: A Country-Level Modeling Study of Policy and Development Correlates
Background: The COVID-19 pandemic disrupted global tuberculosis (TB) con-trol efforts, leading to a surge in TB-related excess mortality, particularly inlow- and middle-income countries. Pandemic mitigation measures—such as lock-downs, reallocation of healthcare resources, and reduced access to diagnosis andtreatment—contributed to delayed TB care and disease progression. Quantifyingthis collateral damage is crucial to bolstering health system resilience. Methods: We estimated country-level excess TB mortality between 2020 and2023 using annual TB mortality data reported by the World Health Organization(WHO). Our approach leverages the SubEpiPredict toolbox of the ensemble sub-epidemic modeling framework, calibrated to pre-pandemic trends (2010–2019) toforecast expected TB deaths in the absence of COVID-19 disruptions. We selectedthe best-fitting model based on AICc and compared projected and reporteddeaths to quantify excess mortality, incorporating both normal and Poissonerror structures. We further examined associations between excess TB mortalityand country-level indicators, including the COVID-19 Stringency Index, GlobalHealth Security (GHS) Index, and Socio-demographic Index (SDI). Results: Our global estimate of 750,000 excess TB deaths aligns closely withWHO’s estimate of 700,000, while offering granular country-level insights withuncertainty bounds. We found substantial geographic heterogeneity, with thehighest TB excess mortality rates observed in southern Africa, South Asia, andparts of South America. Countries with high GHS or SDI scores did not nec-essarily exhibit lower excess TB mortality, suggesting that pandemic-specificdisruptions and competing priorities may have overridden structural advantages.Weak-to-moderate correlations were observed between excess mortality and pan-demic stringency, peaking in 2021 and waning by 2022, possibly reflecting healthsystem adaptation. Conclusion: This study presents a systematic, model-based analysis of globalexcess TB mortality during the COVID-19 pandemic, emphasizing disparities inpandemic response impacts across countries. The findings highlight the need forintegrated and resilient public health systems capable of maintaining essentialservices amid global crises. Our methodology can support real-time monitor-ing of collateral effects of pandemics on endemic diseases and guide strategicinvestments in TB surveillance and care continuity.
- Open Access
Distance-balancing of cube-connected cycles graphs
We show that cube-connected cycles graphs $CCC_n$ are distance-balanced, and nicely distance-balanced if and only if $n$ is even.Open AccessDistance-balancing of cube-connected cycles graphs
We show that cube-connected cycles graphs $CCC_n$ are distance-balanced, and nicely distance-balanced if and only if $n$ is even.